MYC and cancer: In cancer, the acetylation state of histones and other proteins is altered, and BRDs promote the expression of many oncogenes, such as c-Myc and Bcl-2, and thus their inhibition provides a way to inhibit cancer cell growth (see also section Inhibitors of Transcription Factor Gene Expression) (Alqahtani et al., 2019).